Nanolaser Device Detects Cancer in Single Cells

January 24, 2006
Nanolaser Device Detects Cancer in Single Cells
Single cells can flow through this nanoscale biocavity laser, enabling malignant cells to be differentiated from normal cells. Courtesy of Sandia National Laboratory.

Using an ultrafast, nanoscale semiconductor laser, investigators at Sandia National Laboratories in New Mexico, have discovered a way of rapidly distinguishing between malignant and normal cells. Moreover, this new technique has the potential of detecting cancer at a very early stage, a development that could change profoundly the way cancer is diagnosed and treated.

Reporting its work in the journal Biomedical Microdevices, a team of researchers led by Paul Gourley, Ph.D., described the methods it used to construct a device that can flow cells one at a time past an ultrafast laser, and how this device revealed that malignant cells have a characteristic optical response that differs from that of a normal cell. This response, the researchers found, arises from the fact that mitochondria, the internal organelles that produce a cell’s energy, are scattered in a chaotic, unorganized manner in malignant cells, while they form organized networks in healthy cells. This difference produces a marked change in the way that malignant cells scatter laser light.

The researchers were then able to show that they could measure this change when flowing individual cells through a “biocavity laser” that Gourley’s group had previously developed. The change shows up as a difference in the fluorescent signal they observed at two different frequencies of light. The investigators note that they are now studying other cellular components to determine if these intracellular structures also have laser-detectable differences between malignant and normal cells.

This work is detailed in a paper titled, “Ultrafast nanolaser flow device for detecting cancer in single cells.” An investigator from the University of California, San Diego, also participated in this study.

An abstract is available through PubMed.

Source: National Cancer Institute

Explore further: I get by with help from my friends: Maintaining immune cells in head and neck cancer

Related Stories

Nanotechnology a 'green' approach to treating liver cancer

November 29, 2016

According to the American Cancer Society, more than 700,000 new cases of liver cancer are diagnosed worldwide each year. Currently, the only cure for the disease is to surgically remove the cancerous part of the liver or ...

Recommended for you

Saturn's bulging core implies moons younger than thought

December 7, 2016

Freshly harvested data from NASA's Cassini mission reveals that Saturn's bulging core and twisting gravitational forces offer clues to the ages of the planet's moons. Astronomers now believe that the ringed planet's moons ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.